Biotechnology Stocks List
Biotechnology Profile
The Biotechnology industry focuses on the development of products and technologies using biological systems, organisms, or derivatives to enhance healthcare, agriculture, and various other applications, primarily through genetic engineering, pharmaceutical development, and bioinformatics.
Biotechnology Summary
Total Stocks
1
Total Market Cap
$8.56M
Avg Market Cap
$8.56M
Total Revenue
$0.00
Average Revenue
$0.00
Biotechnology Compare
Profile
| Ticker | Name | Description | Sector | Industry | Market Cap | |
|---|---|---|---|---|---|---|
| XCUR | Exicure | Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie Inc. to develop SNA-based treatments for hair loss disorders; and collaboration agreement with Ipsen S.A. to research, develop, and commercialize novel spherical nucleic acids for Huntington's disease and Angelman syndrome. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois. | Healthcare | Biotechnology | $8.56M |
Performance Comparison
1D Change %
List Weighting
Biotechnology Performance
Market Cap Weight 10%
| List | 1D | 5D | 1M | 3M | 6M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|
| Biotechnology | 35.86% | |||||||
| S&P 500 | 0.37% |
| List | 1D | 5D | 1M | 3M | 6M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|
| Biotechnology | 35.86% | |||||||
| S&P 500 | 0.37% |
| List | 1D | 5D | 1M | 3M | 6M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|
| Biotechnology | 35.86% | |||||||
| S&P 500 | 0.37% |